
NIH Study: Oral GLP-1 Drugs May Suppress Addiction Cravings by Targeting Brain's Reward System
New NIH-funded research reveals that oral small-molecule GLP-1 drugs like orforglipron suppress hedonic feeding by modulating the central amygdala, opening potential pathways for treating substance use disorders.



































